Novast Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?
NOVAST LABS has eighty-four approved drugs.
There are three tentative approvals on NOVAST LABS drugs.
Summary for Novast Labs
| US Patents: | 0 |
| Tradenames: | 80 |
| Ingredients: | 63 |
| NDAs: | 84 |
Drugs and US Patents for Novast Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs | CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | TABLET;ORAL | 205087-001 | Sep 23, 2015 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novast Labs | LARIN 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-21 | 202996-001 | Mar 20, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novast Labs | CHABELINA FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 202962-001 | Apr 15, 2020 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novast Labs | LARIN 24 FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 202994-001 | Feb 18, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novast Labs | DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 208357-002 | Jun 6, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novast Labs | FENOFIBRATE (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 207564-003 | Apr 19, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
